Orange Health Labs hits ₹180 cr ARR pitching 60-min collection, 6-hr reports against Dr Lal, Metropolis
Backed by Accel and General Catalyst, Orange Health Labs is processing 300,000 samples a month in Bengaluru at 20% Ebitda margin, scaling a quick-commerce diagnostics model across Delhi, Hyderabad and Mumbai to challenge incumbents in India's fragmented $15-16 bn market by 2030.
What happened
Orange Health Labs is scaling on-demand diagnostics with 60-minute home collection and 6-hour reports, hitting ₹180 cr ARR across four metros, challenging Dr
Key facts
- ₹180 crore ARR
- 300,000 samples/month Bengaluru
- 20% Ebitda profitability Bengaluru
- 60-minute collection
- 6-hour reports
- $15-16 billion market by 2030
- Dr Lal ₹2,763 cr FY26 revenue
- Metropolis ₹1,646 cr FY26
Why this matters
Accel and General Catalyst backing plus proven unit economics make Orange Health a strategic acquisition target for Dr Lal or Metropolis seeking instant quick-commerce capability rather than a multi-year organic build.